Upstream Bio, Inc. Revenue 2023–2025
Upstream Bio, Inc. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Upstream Bio, Inc. revenue for the quarter ending March 31, 2026 was 1.0 M, a 82.69% increase year-over-year.
- Upstream Bio, Inc. revenue for the twelve months ending March 31, 2026 was 3.2 M, a 35.41% increase year-over-year.
- Upstream Bio, Inc. annual revenue for 2025 was 2.9 M, a 20.42% increase from 2024.
- Upstream Bio, Inc. annual revenue for 2024 was 2.4 M, a 0.42% decrease from 2023.
- Upstream Bio, Inc. annual revenue for 2023 was 2.4 M.
Upstream Bio, Inc. (UPB) — Frequently Asked Questions
Upstream Bio, Inc. (UPB) is a publicly traded US company. It has a market capitalization of $336M. In fiscal 2025 it reported revenue of $3M and net income of -$143M. Explore UPB's stock price, financial statements, earnings history, margins and key ratios below.
What is Upstream Bio, Inc.'s market cap?
Upstream Bio, Inc. (UPB) has a market capitalization of $336M.
What is the UPB stock price?
UPB trades at $6.23 (-0.80% on the day).
How much revenue does Upstream Bio, Inc. make?
Upstream Bio, Inc. reported revenue of $3M in fiscal 2025.
Is UPB profitable?
In fiscal 2025, Upstream Bio, Inc. reported net income of -$143M.